This advert is not available!
Lund University was founded in 1666 and is repeatedly ranked among the world’s top universities. The University has around 47 000 students and more than 8 800 staff based in Lund, Helsingborg and Malmö. We are united in our efforts to understand, explain and improve our world and the human condition.
Lund University welcomes applicants with diverse backgrounds and experiences. We regard gender equality and diversity as a strength and an asset.
Description of the workplace
Schmidtchen lab conducts world-leading research in innate immunity and wound healing, and has long-term support from the Swedish Research Council, which in Nov 2020 ranked the project as No. 1 in medicine. The focus for the past 2 decades has been on studies of our innate immunity mechanisms and the development of new therapy concepts for infective-inflammatory diseases – from wound healing to systemic applications. Those who work with the projects in the team include 3 associate professors/senior researchers, technical personnel, and MDs. Collaborations with many external and internal stakeholders are ongoing as well. The therapy concepts are developed in collaboration with biotech companies at Medicon Village, Lund.
Within the department, we ensure a good working environment with respect and consideration in our relationships with each other. We are constantly working to create the conditions for job satisfaction, development and participation for all employees.
What we offer
Lund University is a public authority, which means that you will have special benefits, generous annual leave and an advantageous occupational pension. We also have a flexitime agreement that creates good conditions for work/life balance. Read more on the University’s website about being a Lund University employee, Work at Lund University
Work duties and areas of responsibility
You will work in a dynamic environment with translational projects involving in vivo studies on rodents, using both infection and inflammation models. Standard microbiology, molecular biology, biochemical studies and in vitro cell models will also complement the projects. Reporting and script writing are an important part of the work.
The projects will follow schedules and the ability to deliver on time is a priority. Finally, the work will involve interactions with biotech companies at Medicon Village working on therapy development and clinical trials.
Qualifications
The requirements for the position are:
- MSc in Human Biology
- PhD in medical sciences
- Knowledge and good experience in in vivo models (rodents) and related analyses such as ELISA, IHC, genotyping.
- Skills in Microsoft package, such as Excel etc, and Prism.
Additional qualifications for the position are:
- In vivo course FELASA
- In vivo courses, such as FELASA
- Be able to handle multiple projects in a multicultural environment
- Previous publications translational medicine and drug development
- Previous experience of work or collaborations with biotech
Further information
The employment is a fixed-term employment (SÄVA) full-time for 8 months.
Desired first day of emplyment is February 1, 2023, or as agreed.
How to apply
You apply for the position via the University’s recruitment system. The application is to include a personal letter describing how you meet the qualification requirements and why you are interested in the position. The application is also to include a CV with a list of publications, a general description of previous research work, a copy of your doctoral degree and any other documents to which you wish to draw attention (copies of degree certificates, grade transcripts, details of referees, letters of recommendation, etc.)
Type of employment | Special fixed-term employment |
---|---|
Contract type | Full time |
First day of employment | 2023-02-01 (eller enligt överenskommelse) |
Number of positions | 1 |
Full-time equivalent | 100 % |
City | Lund |
County | Skåne län |
Country | Sweden |
Reference number | PA2022/4224 |
Contact |
|
Union representative |
|
Published | 11.Jan.2023 |
Last application date | 24.Jan.2023 11:59 PM CET |